Clinical trial
Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or…
NCT00002599 · Medical Research Council, Other · Unknown status
Key facts
| NCT number | NCT00002599 |
|---|---|
| Title | Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma |
| Official title | MYELOMA VII MEDICAL RESEARCH COUNCIL WORKING PARTY ON LEUKEMIA IN ADULTS: MYELOMATOSIS THERAPY TRIAL |
| Lead sponsor | Medical Research Council, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Biological, Drug, Radiation |
| Interventions | filgrastim, recombinant interferon alfa, sargramostim, carmustine, cyclophosphamide, doxorubicin hydrochloride, melphalan, methylprednisolone, prednisone, vincristine sulfate and 2 more |
| Enrollment | 750 |
| Start date | Sep 1, 1994 |
| First posted | May 21, 2004 |
| Last update posted | Dec 19, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: